Drug intelligence / Profile preview

Gynoflorelle

Development stage
Unknown
Lead developer
Medinova
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Vaginal
01

Overview

Gynoflorelle is a vaginal probiotic product developed and marketed by Medinova AG. It contains a high concentration of the specific bacterial strain *Lactobacillus acidophilus* KS400. The product is designed to restore and maintain a healthy vaginal microbiome, particularly following antibiotic or antifungal treatment, or during periods of hormonal fluctuation that disrupt the natural flora. By colonizing the vaginal mucosa, the lactobacilli produce lactic acid, which lowers the vaginal pH to a physiological level (approximately 4.0–4.5), thereby creating an environment that inhibits the growth of pathogenic bacteria and fungi. Unlike Medinova's related prescription product Gynoflor, Gynoflorelle does not contain the estrogen component estriol, making it a non-hormonal option for managing vaginal dysbiosis and preventing recurrent infections such as bacterial vaginosis and candidiasis.

Brand names
Gynoflorelle
Other names
Lactobacillus acidophilus KS400

Beyond the preview

Go deeper on Gynoflorelle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynoflorelle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call